Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers Nanobiotix SA NBTX Q4 2025 Earnings Wide EPS Miss Stock Edges Higher on Clinical Progress PASG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally ProAssurance Corporation PRA Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Mount ACN Q1 2026 Earnings EPS Beats Estimates by 213 Amid Consulting Demand